Compile Data Set for Download or QSAR
Report error Found 6 Enz. Inhib. hit(s) with all data for entry = 13232
TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Beijing Tide Pharmaceutical

US Patent
LigandPNGBDBM769513(US12410192, Compound D3)
Affinity DataIC50: 1.09nMAssay Description:Assay Method: (1) A compound stock solution was prepared and diluted 3× to give a compound dilution; 10 nL of the compound dilution was transferred t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/17/2025
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Beijing Tide Pharmaceutical

US Patent
LigandPNGBDBM769512(US12410192, Compound D2)
Affinity DataIC50: 3.84nMAssay Description:Assay Method: (1) A compound stock solution was prepared and diluted 3× to give a compound dilution; 10 nL of the compound dilution was transferred t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/17/2025
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Beijing Tide Pharmaceutical

US Patent
LigandPNGBDBM769511(US12410192, Compound D1)
Affinity DataIC50: 4.53nMAssay Description:Assay Method: (1) A compound stock solution was prepared and diluted 3× to give a compound dilution; 10 nL of the compound dilution was transferred t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/17/2025
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Beijing Tide Pharmaceutical

US Patent
LigandPNGBDBM769514(US12410192, Compound D4)
Affinity DataIC50: 10.1nMAssay Description:Assay Method: (1) A compound stock solution was prepared and diluted 3× to give a compound dilution; 10 nL of the compound dilution was transferred t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/17/2025
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Beijing Tide Pharmaceutical

US Patent
LigandPNGBDBM769515(US12410192, Compound D5)
Affinity DataIC50: 35.9nMAssay Description:Assay Method: (1) A compound stock solution was prepared and diluted 3× to give a compound dilution; 10 nL of the compound dilution was transferred t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/17/2025
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Beijing Tide Pharmaceutical

US Patent
LigandPNGBDBM50029668(AZD-9291 | Osimertinib | US10085983, Compound AZD-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Assay Method: (1) A compound stock solution was prepared and diluted 3× to give a compound dilution; 10 nL of the compound dilution was transferred t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/17/2025
Entry Details
US Patent